Skip to main content

Table 1 Clinical laboratory data during the treatment of vadadustat

From: Reduced blood glucose levels by the combination of vadadustat in an elderly patient with chronic kidney disease who was receiving mitiglinide and sitagliptin: a case report

 

Unit

Before the initiation of vadadustat (day -49)

At the initiation of vadadustat (day 0)

At the initiation of daprodustat (day 57)

Total protein

g/dL

7.2

7.1

7.6

Albumin

g/dL

3.9

4.1

4.0

BUN

mg/dL

40.4

44.1

43.2

Creatinine

mg/dL

1.91

1.79

1.95

eGFR

mL/min/1.73m2

28.0

30.1

27.4

Na

meq/L

137

139

136

K

meq/L

5.5

5.2

5.8

Cl

meq/L

105

105

103

AST

U/L

29

26

38

ALT

U/L

25

23

38

LDH

U/L

214

208

241

γ-GTP

U/L

13

12

13

T-Bil

mg/dL

0.3

0.4

0.4

Glucose

mg/dL

118

130

94

CPK

U/L

383

234

262

HDL-c

mg/dL

49.2

54.4

48.9

LDL-c

mg/dL

53

56

53

HbA1c(NGSP)

%

7.4

7.4

7.5

HbF

%

1.3

1.3

1.3

White blood cell

 × 103/μL

6.09

7.34

7.47

Red blood cell

 × 103/μL

3.26

3.28

3.43

Hemoglobin

g/dL

9.8

9.9

10.4

Hematocrit

%

30.8

30.8

32.7

MCV

fL

94.5

93.9

95.3

MCH

pg

30.1

30.2

30.3

MCHC

%

31.8

32.1

31.8

Platelet

 × 103/μL

161

131

152

  1. Abbreviations: BUN blood urea nitrogen, eGFR estimated glomerular filtration rate, Na sodium, K potassium, Cl chloride, AST aspartate aminotransferase, ALT alanine aminotransferase, LDH lactate dehydrogenase, γ-GTP gamma-glutamyl transpeptidase, T-Bil total bilirubin, CPK creatinine phosphokinase, HDL-c high-density lipoprotein-cholesterol, LDL-c low-density lipoprotein-cholesterol, HbA1c (NGSP) hemoglobin A1c (National Glycohemoglobin Standardization Program), HbF fetal hemoglobin, MCV mean corpuscular volume, MCH mean corpuscular hemoglobin, MCHC mean corpuscular hemoglobin concentration